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A novel method for detecting drug resistance in Mycobacterium tuberculosis using
mycobacteriophage 2Φ GFP10 was evaluated with clinical isolates. The phage facilitates
microscopic fluorescence detection due to the high expression of green fluorescence
protein which also simplifies the operative protocol as well. A total of 128 clinical isolates
were tested by the phage assay for isoniazid (INH), rifampin (RIF), and streptomycin
(STR) resistance while conventional drug susceptibility test, by MGIT960, was used
as reference. The sensitivities of 2Φ GFP10 assay for INH, RIF, and STR resistance
detection were 100, 98.2, and 89.3%, respectively while their specificities were 85.1,
98.6, and 95.8%, respectively. The agreement between phage and conventional assay
for detecting INH, RIF, and STR resistance was 92.2, 98.4, and 93.0%, respectively. The
2
Φ GFP10-phage results could be available in 2 days for RIF and STR, while it takes
3 days for INH, with an estimated cost of less than $2 to test all the three antibiotics.
The 2Φ GFP10-phage method has the potential to be a valuable, rapid and economical
screening method for detecting drug-resistant tuberculosis.
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INTRODUCTION
Reduction in transmission of drug resistant tuberculosis (TB) and improved patient management
requires timely diagnosis of drug resistant bacilli. Presence of drug-resistant M. tuberculosis
bacilli is confirmed by genotypic and phenotypic drug susceptibility testing (DST). Genotypic
approaches with short turnaround time are based on identification of well-known antibiotic
resistance-conferring gene mutations. Despite active research, not all TB drugs can have genotypic
drug-susceptibility testing since the genetic basis of resistance may be complex or incompletely
characterized (Kruuner et al., 2003; Jain et al., 2011; Cui et al., 2013; Zhang et al., 2015). Phenotypic
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assays observe the bacterial response to antibiotics in vitro
without limitation to any particular antibiotic, allele, or
working mechanism although the phenotypic DST is often time
consuming.The conventional DST, based on solid medium, takes
about 4–6weeks after the isolation ofM. tuberculosis, on the other
hand BACTEC MGIT960 requires 10–14 days after acquiring a
positive culture. Therefore, it is imperative to outline a further
rapid, accurate, inexpensive DST method for the diagnosis of
drug resistanceM. tuberculosis.
Phage based methods have been used for drug resistance
detection ofM. tuberculosis since about two decades ago, such as
bacteriophage D29 (Wilson et al., 1997) and luciferase reporter
phages (LRPs) (Jacobs et al., 1993). A novel, high-intensity
mycobacteria-specific fluorophage (Φ2GFP10) was described
recently with good results in pre-clinical evaluation of drug
resistant tuberculosis (Jain et al., 2012).Φ2GFP10 is an improved
second generation fluorescent reporter phage which expresses gfp
(green fluorescence protein ) under the control of PL promoter
of mycobacterium phage L5 (Guo and Ao, 2012; Jain et al.,
2012) and have intensity 100 times brighter than the previous
generation of fluorescent reporter phages (Piuri et al., 2009).
Unlike the LRPs (Jacobs et al., 1993), the Φ2GFP10 reporter
phage does not require exogenous luciferase substrate and
can yield more stable and microscopically detectable intensive
fluorescence. The presented study has evaluated the performance
of this in-house fluorophage method to determine the rifampicin
(RIF), isoniazid (INH), and streptomycin (STR) resistance in
a high drug-resistant setting. Here we have evaluated the
performance of Φ2GFP10 phage for detecting drug resistance
from M. tuberculosis clinical isolates, and also developed a new
phage assay method using fluorescent microplate reader.
MATERIALS AND METHODS
Strains
A total of 128 clinical M. tuberculosis strains were isolated from
patients with suspected drug-resistant TB patients visiting the
Beijing chest hospital (Beijing, China) from April to June 2014.
All of the isolates were identified as M. tuberculosis complex
(MTBC) strains by performing a growth test on 500µg/ml
p-Nitrobenzoic Acid containing Löwenstein-Jensen medium
(Tsukamura and Tsukamura, 1964). The drug susceptibility of the
isolates was determined by MGIT960 SIRE kits according to the
manufacturer’s protocol. The critical concentrations used were
as follows: INH (0.1µg/ml), RIF(1.0µg/ml), STR(1.0µg/ml).
Ultimately, 61, 56, and 56 were defined as resistant to INH, RIF
and STR respectively by MGIT960 system. The laboratory M.
tuberculosis H37Rv (ATCC 27294) strain was used in all batches
as control.Technique round was demonstrated in Figure 1.
Phage Stock Preparation
The fluorophage, Φ2GFP10 was constructed by Dr William R.
Jacobs’ laboratory in Albert Einstein University (New York,
USA). The stocks were prepared by growing M. smegmatis
strain (mc2155) in the 7H9, containing 10% oleic albumin
dextrose catalase (OADC), to an optical density of 1.0 detected
by spectrophotometer at 600 nm wavelength. Then 300µl cell
suspension and 200µl Φ2GFP10 were mixed and incubated at
room temperature for 30min. Subsequently, 3ml 7H9 containing
0.75% agar was added to the tube, the contents were brieflymixed
and poured onto a 100-mm Petri dish containing 7H10-OADC.
After the top-agar was solidified, the dish was incubated at 30◦C
for 48 h. Then 3ml MP buffer [50mM Tris (pH 7.6), 150mM
NaCl, 10mM MgCl2, and 2mM CaCl2] was pipetted onto the
plates and then incubated on an orbital shaker for 6 h. The buffer
was then collected and passed through a 0.22µmMillipore filter
membrane. The phage titers were determined by serial dilution
method and the phage density was adjusted to approximately
1010 plaque forming unit (pfu)/ml for further use. The phage
stock was stable when stored at 4◦C as no appreciable drop in
titer occurred for at least 6 months.
Φ
2GFP10 Assay by Microscopy
Examination
INH, RIF, and STR were obtained from Sigma-Aldrich. INH and
STR were dissolved in water; RIF was dissolved in DMSO. The
stock solutions were 20mg/ml, 2mg/ml and 4mg/ml for INH,
RIF, and STR, respectively. All stock solutions were stored at
−80◦C during experimentation. Fresh colonies on Löwenstein-
Jensen media were suspended and homogenized with sterile
saline and the cell density was adjusted to 1 McFarland turbidity.
A 1ml aliquot was harvested by centrifugation and the sediment
was re-suspended with 250µl 7H9-OADC in the absence of
Tween 80. The desired drugs would be added at this step, when
needed, at the following finial concentrations: 20µg/ml for INH,
2µg/ml for RIF, or 4µg/ml for STR. The tubes were incubated at
37◦C for 24 h, or 48 h specifically for INH tests. From the stock,
containing 1010 pfu fluorophage perml, 100µl volumewas added
to each tube to obtain amultiplicity of infection (MOI) of 100, the
tubes were then incubated at 37◦C for 16 h. After adding 350µl
of 4% paraformaldehyde in phosphate-buffered saline (PBS) to
each tube, the reaction mixtures, left at room temperature for
90min to ensure killing of the bacteria, were then centrifuged
at 12,000 g for 15min to remove excess phage and media. The
pellet was re-suspended with 10µl 7H9 media. Five micro liter
re-suspension was spotted on a glass slide and visualized by a
fluorescence microscope. The criterion for resistance with phage
assay was the presence of at least one fluorescent bacillus per 50
high power fields (Rondon et al., 2011).
Φ
2GFP10 Assay by Microplate Reader
To detect fluorescence of Φ2GFP10 in a 96 well format relative
light unit (RLU) of fluorescence was measured by a fluorescent
microplate reader (Berthold LB970, Germany). The wavelength
of excitation and emitted light was 485 and 535 nm respectively
and the counting time was 5 s. Each test was performed in
triplicate and the mean value was used for interpretation.
After removing excess phage and media by centrifuging, the
pellet was re-suspended in 200 µl PBS, and then, the RLU
of the plate was read. The influence of drug exposure on the
fluorescence production of the bacilli was interpreted by the
remaining fluorescence rate (RFR), calculated by the following
formula: (reaction counts-blank counts)/(positive control counts
–blank counts) ×100% (“reaction” indicates the well with drug
exposure; “blank” indicates the well without drug and phage;
“positive control” indicates the reaction without drug). Precision
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FIGURE 1 | Technique route of the study.
of the assay was determined with quintuple measurements of
the following three strains: H37Rv which was susceptible to all
the three tested drugs, strain 14,301 which was resistant to all
the three tested drugs and strain 14,161 which was resistant to
INH and STR but susceptible to RIF. The stability of fluorescence
was determined by detecting the same samples at 0, 4, and 24 h,
respectively. All the reactions were performed in triplicate.
Statistical Analysis
According to MGIT960 phenotypic outcomes, receiver-
operation characteristic (ROC) analysis was performed using
SPSS (version 17.0) and used to define a cutoff value for phage
plate reader assay. Kappa value was calculated to compare the
method between Φ2GFP10 assay and MGIT960 phenotypic
outcomes. Sensitivity, specificity, positive predictive value
(PPV), negative predictive value (NPV) was calculated from
the following URL: http://vassarstats.net. The discriminative
power of fluorescent microplate reader for drug resistance was
analyzed using ROC curve and area under the curve (AUC). The
optimal cut-off value was defined as the one with the least (1 −
sensitivity)2 + (1− specificity)2 value (Shu et al., 2013).
RESULTS
Φ
2GFP10 Assay by Microscopy
According to the outcomes of MGIT960, the sensitivity of
Φ
2GFP10 assay for detecting INH, RIF and STR resistance were
100, 98.2, and 89.3% respectively whereas the specificities were
85.1, 98.6, and 95.8% respectively. The agreement between phage
assay and MGIT960 for detecting INH, RIF and STR resistance
was 92.2, 98.4, and 93.0%, respectively (see Table 1).The Kappa
coefficient between Φ2GFP10 assay and MGIT960 phenotypic
outcomes for INH,RIF and STR were 0.85, 0.97, and 0.856,
respectively.
Φ
2GFP10 Assay by Fluorescent Microplate
Reader
In the preliminary validation of the assay among the 3 tested
isolates, the stability tests demonstrated that the fluorescence was
stable for at least 24 h at 4◦C (see Table 2). The coefficient of
variation (CV) of RLU among the tested isolates in quintuple
ranged from 1.22 to 6.73%, with the mean value at 4.67± 1.26%.
In the validation assays using clinical isolates, in contrast to the
phenotypic DST, the AUC under the ROC curve of INH, RIF and
STR were 0.957, 0.960, 0.917, and the optimal cutoff value for
each drug has been listed in Table 3 and Figure 2. The sensitivity
of Φ2GFP10 assay by plate reader for detecting INH, RIF and
STR resistance, according to the cutoff values, were 86.9, 89.3,
and 83.9%, respectively, while the specificity for INH, RIF and
STR resistance detection were 94.0, 90.3, and 87.5%, respectively.
The Kappa coefficient between Φ2GFP10 assay and MGIT960
phenotypic outcomes for INH,RIF and STR were 0.73, 0.79,
and 0.71,respectively. Furthermore, evaluation of the RFR value
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TABLE 1 | Results and performance parameters: Φ2GFP10 assay by microscopy vs. MGIT960 system.
Antibiotics No. of isolates % (95% CI)
MGIT960 R MGIT960 S Total Sensitivity Specificity PPV NPV
Phage R Phage S Phage R Phage S
INH 61 0 10 57 128 100.0 (92.6–100.0) 85.1 (73.8–92.2) 85.9 (75.2–92.7) 100.0 (92.1–100.0)
RIF 55 1 1 71 128 98.2 (89.2–99.9) 98.6 (91.5–99.9) 98.2 (89.2–99.9) 198.6 (91.5–99.9)
STR 50 6 3 69 128 89.3 (77.4–95.6) 95.8(87.5–98.9) 94.3 (83.4–98.5) 92.0 (82.8–96.7)
R, resistant; S, sensitive.
TABLE 2 | The stability and precision of fluorescent microplate reader assay.
Stains Time (h) The counts of Fluorescent microplate reader (mean±SD)
Blank control Positive control INH (RFR*) RIF (RFR*) STR (RFR*)
H37Rv 0 5476.00 ± 342.39 9902.00 ± 503.95 6926.00 ± 84.44 (32.76)* 6296.00 ± 267.82 (18.53) 6540.00 ± 256.12 (24.04)
4 5336.00 ± 359.35 9626.00 ± 515.10 6792.00 ± 181.30 (33.94) 6974.00 ± 323.77 (26.53) 6766.00 ± 253.24 (33.33)
24 5218.00 ± 299.03 10088.00 ± 624.40 6414.00 ± 283.16 (24.60) 6364.00 ± 335.01 (23.53) 6476.00 ± 302.62 (25.83)
14031 0 5144.00 ± 184.07 8650.00 ± 347.20 8058.00 ± 297.19 (83.11) 8688.00 ± 413.55 (108.08) 8314.00 ± 533.32 (90.42)
4 5140.00 ± 252.59 8410.00 ± 312.17 7992.00 ± 342.15 (87.22) 8302.00 ± 452.46 (97.70) 8352.00 ± 448.74 (98.23)
24 5318.00 ± 332.60 8558.00 ± 257.04 8230.00 ± 278.57 (89.88) 8470.00 ± 527.4 (97.28) 8516.00 ± 310.85 (98.70)
14161 0 4568.00 ± 273.17 8354.00 ± 417.17 7694.00 ± 327.46 (82.57) 5380.00 ± 185.07 (21.45) 7612.00 ± 353.09 (80.40)
4 4576.00 ± 298.63 8338.00 ± 363.00 7566.00 ± 458.34 (79.48) 5768.00 ± 206.57 (31.69) 7650.00 ± 401.25 (81.71)
24 4688.00 ± 80.44 8502.00 ± 378.31 7948.00 ± 382.84 (85.47) 5320.00 ± 257.97 (16.57) 7884.00 ± 477.94 (83.80)
*Remaining fluorescence rate (RFR) = (reaction -blank )/(positive control–blank ) × 100% (“reaction” indicates the well with drug exposure; “blank” indicates the well without drug and
phage; “positive control” indicates the reaction without drug).
according to the susceptibility predictability demonstrated that
when the RFR is lower than 45% the NPV for INH, RIF and STR
were 98.0, 98.2, and 87.5%, respectively. Similarly, when the ratio
was higher than 60%, the PPV for INH, RIF and STR were 92.6,
97.9, and 95.3%, respectively. When the ratio was between 45 and
60%, then the outcome should be interpreted as undetermined
(see Table 4).
DISCUSSION
Significant efforts are being made to develop rapid, simple
and accurate tests for drug- resistant M. tuberculosis. One
of such technologies currently been worked at is based on
using bacteriophages (Banaiee et al., 2008; Piuri et al., 2009;
Rondon et al., 2011; Jain et al., 2012; Sivaramakrishnan et al.,
2013). LRP have been used for identifying drug resistance by
detecting the luminescence produced by LRP after their infection
in M. tuberculosis. These assays classify the samples as drug-
susceptible if no luminescence is detected in the luminescence
drug-containing samples. A meta-analysis showed that the
sensitivity and specificity of luciferase reporter phage for rapid
detection of RIF resistance in M. tuberculosis ranged from 92
to 100% and 89 to 100% (Minion and Pai, 2010). Although
this method has shown high sensitivity and high specificity,
a relatively expensive luminometer is required. The newly
constructed phage Φ2GFP10 facilitates the microscopic signal
detection since it yields 100-folds higher fluorescence signal per-
cell than any previously described reporter phages (Jain et al.,
2011). Meanwhile, as the intensive fluorescence increased the
contrast between reaction and background, tedious washing steps
were not necessary for phage assay, so the Φ2GFP10 assay was
easier to perform than the other phage assays (Rondon et al.,
2011).
In this study, drug resistance detection by Φ2GFP10 assay
yielding applicable sensitivities and specificities, especially for
RIF. A recent report also obtained great consistency between
Φ
2GFP10 assay and GeneXpert for RIF resistance diagnosis
(O’Donnell et al., 2015). Fluorescent microscopy may be a
limiting factor for Φ2GFP10 assay application due to its cost,
whereas less expensive and simpler fluorescent microscopes
using light emitting diodes (LED) have been applied for smear
test of tuberculosis in various clinical laboratories (Marzouk et al.,
2013; Reza et al., 2013; Xia et al., 2013) and they could readily be
adapted forΦ2GFP10 assay. The reagents for fluorophage growth
and amplification are inexpensive, safe, and universally available.
The total cost for the 3-drug test per strain was less than US $2.
Additionally, fixation of the sample with paraformaldehyde prior
to analysis overcomes the substantial biosafety concerns.
In our study, even though a longer drug exposure time of 48 h
for INH, the specificity was still lower than those of RIF and STR
whose drug exposure time was 24 h. Those observations were
consistent with other mycobacteriophage-based assays (Rondon
et al., 2011). The anti-TB mechanism of INH involves inhibiting
the synthesis of mycolic acid of cell wall (Eltringham et al., 1999),
which is a slow process compared with the quickly bactericidal
activities of RIF and STR, therefore the bacilli can stay alive
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TABLE 3 | Results and performance parameters: fluorescent microplate reader vs. MGIT960 system.
Antibiotics AUC Cutoff (%) % (95% CI)
sensitivity specificity PPV NPV
INH 0.957 55.00 86.9 (75.2–93.8) 94.0 (84.7–98.1) 93.0 (82.2–97.7) 88.7 (78.5–94.7)
RIF 0.960 53.60 89.3 (77.4–95.6) 90.3 (80.4–95.7) 87.7 (75.7–94.5) 91.5 (81.9–96.5)
STR 0.917 48.65 83.9 (71.2–91.9) 87.5 (77.1–93.8) 83.9 (71.2–91.9) 87.5 (77.1–93.8)
FIGURE 2 | Receiver operating characteristic curves of fluorescent microplate reader in detecting drug resistance according to BactecMGIT 960
system. (A) INH; (B) RIF; (C) STR.
TABLE 4 | Results and performance parameters by sectional outcomes
interpretation: fluorescent microplate reader vs. MGIT960 system.
Drug RFR No. of isolates MGIT960 DST outcomes
R S
INH <45% 51 1 50
45–60% 23 10 13
>60% 54 50 4
RIF <45% 56 1 55
45–60% 25 9 16
>60% 47 46 1
STR <45% 64 8 56
45–60% 21 7 14
>60% 43 41 2
R, resistant; S, sensitive; RFR, remaining fluorescence rate.
for quite a while even when they are sensitive to INH. The
fluorophage could infect such bacilli and produce fluorescence
signal which decreased the specificity of the assay. To enhance the
bactericidal activity of INH, we increased the INH concentration
for phage assay to 20µg/ml, which was dramatically higher than
those of previous studies (Xia et al., 2013; Zhang et al., 2015).
However, the specificity was still lower for INH than those of
RIF and STR, which indicating the INH tolerance deviation for
clinical strains was universal.
First-line-drug ethambutol (EMB) also affects the cell wall
construction in M. tuberculosis, and is a bacteriostatic drug
rather than a bactericidal drug. We attempted to develop a
Φ
2GFP10 assay for EMB, but the pilot test demonstrated that
even an exposure concentration of 50µg/ml could not lead to
obvious CFU loss. A previous study reported low concordance
(53%) between the phage amplified biologically assay and
resistance ratio method for EMB, which they attributed to the
bacteriostatic role of EMB both in vitro and in a macrophage
model (Eltringham et al., 1999). Therefore, the Φ2GFP10 assay
might only be feasible to test the rapid-action bacteriocidal drugs.
Although we acquired favorable sensitivity and specificity
for Φ2GFP10 assay by microscopy, we found that microscopic
examination process is experience dependent, and a lot of
time is required when handing a batch of samples. So we
developed a phage assay to interpret the outcomes simply by
fluorescence plate reader, which can read a 96-well plate in
10min. We monitored the fluorescence diminishing after the
bacilli were exposed to the tested drugs. When categorized
the RFR lower than 45% as “susceptible,” greater than 60% as
“resistant,” while between 45 and 60% as undetermined, plate
reader could interpret over 80% of the test strains successfully
for all the 3 drugs, with 95.24% (100/105), 98.06% (101/103),
and 90.65% (97/107) consistency with MGIT960 system for
INH, RIF, and STR susceptibility tests, respectively. Therefore,
we suggest interpreting the outcomes in sections to increase
the reliability of the assay. For undetermined samples, we
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suggest to recheck by microscopy to produce more reliable
results.
Like other fluoromycobacteriophages, Φ2GFP10 assay could
not discriminate between M. tuberculosis and other members of
MTBC species (Riska et al., 1997). For the settings with high
isolation rate of nontuberculous mycobacteria, one should be
cautious to report drug resistance without MTBC identification.
In summary, the Φ2GFP10 assay is a rapid, simple and
inexpensive DST method. In clinical laboratories with limited
resources, the Φ2GFP10 based assay has the potential to be used
for drug resistance diagnosis of tuberculosis.
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